IRCT201705191556N99招募中2 期
Amantadin as adjuvant therapy in the treatment of moderate to severe OCD: a double blind randomized trial with placebo control
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1- Age between 18-60 years old; 2- Diagnosis of OCD based on DSM-5; 3- Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale.
排除标准
- •1- Substance dependence; 2- IQ <70; 3- Any other mental disorder on axis I; 4-Any serious cardiac, renal or hepatic disease; 5- receiving psychotropic medications during the last 6 weeks; 6- pregnancy or breast feeding; 7- Rising liver transaminases to three times the upper limit of normal or higher.
研究者
相似试验
已完成
2 期
Memantine in the treatment of obsessive-compulsive disorderObsessive-compulsive disorderIRCT201106031556N22Tehran University of Medical Sciences40
进行中（未招募）
1 期
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virusEUCTR2021-001144-98-PLSamodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie200
尚未招募
2 期
Theanine as an adjuvant therapy in the treatment of major depressive disorderMajor Depressive Disorder.Major depressive disorder, single episode, severe without psychotic featuresF32.2IRCT20090117001556N131Tehran University of Medical Sciences50
已完成
3 期
post operative pain controlpost operative pain control.Antiparkinsonism drugsIRCT201406201772N13Tabriz university of medical science/ Vice chancellor of reseach60
已完成
2 期
Effect of co-administration of Amantadine and Aspirin on fatigue in patients with multiple sclerosisMultiple scerosis.Multiple sclerosisIRCT201112208430N3Kerman Neuroscience Reserch Center45